Nayla Nuren Snigdha

Ms. Nayla Nuren Snigdha

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Diabetology
Verified
Journal Article
Open access
PDF file
Prawej AnsariPrawej Ansari
Prawej Ansari
Noushin TabasummaNoushin Tabasumma
Noushin Tabasumma
NSNayla Nuren Snigdha
Nayla Nuren Snigdha
NSNawfal Hasan Siam
Nawfal Hasan Siam
Srirachana Venkata Naga Ravi PanduruSrirachana Venkata Naga Ravi Panduru
Srirachana Venkata Naga Ravi Panduru
Yasser Abdel-WahabYasser Abdel-Wahab
Yasser Abdel-Wahab
Diabetes mellitus is one of the most frequently occurring metabolic disorders (DMs), impairing healthy life around the globe, with mild-to-severe secondary complications. DM is associated with secondary complications, including diabetic retinopathy (DR), which damages the retina and can lead to vision loss. Diabetic patients often suffer from extreme retinal capillary aneurysms, hemorrhage, and edema, which is likely to lead to non-proliferative or proliferative diabetic retinopathy (NPDR or PDR) and diabetic macular edema (DME). Several epidemiological studies have illustrated that the occurrence of DR can vary by age of diabetes onset, diabetes type, and ethnicity. Although DR is very well-known, the complexity of its etiology and diagnosis makes therapeutic intervention difficult and challenging. We have reviewed different pathological aspects of diabetic retinopathy and its underlying mechanism of occurrence. In this review, we aim to provide an in-depth understanding and illustration of the progression of diabetic retinopathy, its pathophysiology, epidemiology, and prospective therapeutic targets.